Fibrosis and subsequent Cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3578-3593

  Mailloux, Adam W ^a   Zhang, Ling ^a   Moscinski, Lynn ^a   Bennett, John M ^b   Yang, Lili ^a,c   Yoder, Sean J ^a   Bloom, Gregory ^a   Wei, Cody ^a   Wei, Sheng ^a   Sokol, Lubomir ^a   Loughran Jr , Thomas P ^d   Epling Burnette, Pearlie K ^a,e  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^d PENN STATE CANCER INSTITUTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE; FIBROBLAST GROWTH FACTOR 2; IMMUNOSUPPRESSIVE AGENT;

ADIPOCYTE; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BIOACCUMULATION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL INFILTRATION; CELL KINETICS; CELL PROLIFERATION; CHROMOSOME SIZE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPENIA; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LYMPHOCYTE COUNT; MALE; MESENCHYMAL STROMA CELL; OSTEOBLAST; PERIPHERAL LYMPHOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SPLENOMEGALY; T LYMPHOCYTE; TELOMERE; TUMOR MICROENVIRONMENT;

AGED; BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PANCYTOPENIA; RETROSPECTIVE STUDIES; TELOMERE;

EID: 84885110455     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203424     Document Type: Article

References (68)

1. Starkebaum, G. 2002. Chronic neutropenia associated with autoimmune disease. Semin. Hematol. 39:121-127.
2. Beyan, E., C. Beyan, and M. Turan. 2007. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 12:257-261.
3. Castillo-Martínez, D., L. M. Amezcua-Guerra, and R. Bojalil. 2011. Neutropenia and the risk of infections in ambulatory patients with systemic lupus erythematosus: a three-year prospective study cohort. Lupus 20:998-1000.
4. Newman, K. A., and M. Akhtari. 2011. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun. Rev. 10:432-437.
5. Lamy, T., and T. P. Loughran, Jr. 2011. How I treat LGL leukemia. Blood 117:2764-2774.
6. Loughran, T. P., Jr., M. E. Kadin, G. Starkebaum, J. L. Abkowitz, E. A. Clark, C. Disteche, L. G. Lum, and S. J. Slichter. 1985. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann. Intern. Med. 102:169-175.
7. Starkebaum, G., T. P. Loughran, Jr., L. K. Gaur, P. Davis, and B. S. Nepom. 1997. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum. 40:624-626.
8. Yang, J., P. K. Epling-Burnette, J. S. Painter, J. Zou, F. Bai, S. Wei, and T. P. Loughran, Jr. 2008. Antigen activation and impaired Fas-induced deathinducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 111:1610-1616.
9. Swerdlow, S. C. O. 2008. International Agency for Research on World Health: WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer (IARC), Lyon, France.
10. Subbiah, V., A. D. Viny, S. Rosenblatt, B. Pohlman, A. Lichtin, and J. P. Maciejewski. 2008. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp. Hematol. 36:1078-1083.
11. Lamy, T., and T. P. Loughran, Jr. 1999. Current concepts: large granular lymphocyte leukemia. Blood Rev. 13:230-240.
12. Plasilova, M., A. Risitano, and J. P. Maciejewski. 2003. Application of the molecular analysis of the T-cell receptor repertoire in the study of immunemediated hematologic diseases. Hematology 8:173-181.
13. Viny, A. D., A. Lichtin, B. Pohlman, T. Loughran, and J. Maciejewski. 2008. Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk. Lymphoma 49:932-938.
14. Coppo, P., J. P. Clauvel, D. Bengoufa, V. Fuentes, V. Gouilleux-Gruart, J. C. Courvalin, and K. Lassoued. 2004. Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides. Am. J. Hematol. 77:241-249.
15. Berliner, N., M. Horwitz, and T. P. Loughran, Jr. 2004. Congenital and acquired neutropenia. Hematology Am. Soc. Hematol. Educ. Program 2004:63-79.
16. Handgretinger, R., A. Geiselhart, A. Moris, R. Grau, O. Teuffel, W. Bethge, L. Kanz, and P. Fisch. 1999. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N. Engl. J. Med. 340:278-284.
17. Kothapalli, R., R. D. Bailey, I. Kusmartseva, S. Mane, P. K. Epling-Burnette, and T. P. Loughran, Jr. 2003. Constitutive expression of cytotoxic proteases and downregulation of protease inhibitors in LGL leukemia. Int. J. Oncol. 22:33-39.
18. Morice, W. G., P. J. Kurtin, A. Tefferi, and C. A. Hanson. 2002. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99:268-274.
19. Smyth, M. J., K. A. Browne, B. F. Kinnear, J. A. Trapani, and H. S. Warren. 1995. Distinct granzyme expression in human CD32 CD56+ large granular-and CD3-CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity. J. Leukoc. Biol. 57:88-93.
20. Epling-Burnette, P. K., J. S. Painter, P. Chaurasia, F. Bai, S. Wei, J. Y. Djeu, and T. P. Loughran, Jr. 2004. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103:3431-3439.
21. Liu, J. H., S. Wei, T. Lamy, P. K. Epling-Burnette, G. Starkebaum, J. Y. Djeu, and T. P. Loughran. 2000. Chronic neutropenia mediated by fas ligand. Blood 95:3219-3222.
22. Liu, E. B., H. S. Chen, P. H. Zhang, Z. Q. Li, Q. Sun, Q. Y. Yang, L. H. Fang, and F. J. Sun. 2012. [Hematopathologic features of T-cell large granular lymphocytic leukemia]. Zhonghua Bing Li Xue Za Zhi 41:229-233.
23. O'Malley, D. P. 2007. T-cell large granular leukemia and related proliferations. Am. J. Clin. Pathol. 127:850-859.
24. Osuji, N., K. Beiske, U. Randen, E. Matutes, G. Tjonnfjord, D. Catovsky, and A. Wotherspoon. 2007. Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology 50:547-554.
25. Ramakrishna, R., P. W. Kyle, P. J. Day, and A. Manoharan. 1995. Evans' syndrome, myelofibrosis and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology 27:255-259.
26. Epling-Burnette, P. K., J. S. Painter, D. E. Rollison, E. Ku, D. Vendron, R. Widen, D. Boulware, J. X. Zou, F. Bai, and A. F. List. 2007. Prevalence and clinical association of clonal T-cell expansions in myelodysplastic syndrome. Leukemia 21:659-667.
27. Thiele, J., H. M. Kvasnicka, F. Facchetti, V. Franco, J. van der Walt, and A. Orazi. 2005. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90:1128-1132.
28. Lennon, D. P., and A. I. Caplan. 2006. Isolation of human marrow-derived mesenchymal stem cells. Exp. Hematol. 34:1604-1605.
29. Sung, K. E., G. Su, C. Pehlke, S. M. Trier, K. W. Eliceiri, P. J. Keely, A. Friedl, and D. J. Beebe. 2009. Control of 3-dimensional collagen matrix polymerization for reproducible human mammary fibroblast cell culture in microfluidic devices. Biomaterials 30:4833-4841.
30. Van Gelder, R. N., M. E. von Zastrow, A. Yool, W. C. Dement, J. D. Barchas, and J. H. Eberwine. 1990. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA 87:1663-1667.
31. Warrington, J. A., A. Nair, M. Mahadevappa, and M. Tsyganskaya. 2000. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol. Genomics 2:143-147.
32. Liu, W. M., R. Mei, X. Di, T. B. Ryder, E. Hubbell, S. Dee, T. A. Webster, C. A. Harrington, M. H. Ho, J. Baid, and S. P. Smeekens. 2002. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18:1593-1599.
33. Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, Dj. Prockop, and E. Horwitz. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
34. Chernousov, M. A., R. C. Stahl, and D. J. Carey. 1998. Schwann cells use a novel collagen-dependent mechanism for fibronectin fibril assembly. J. Cell Sci. 111:2763-2777.
35. Broxmeyer, H. E. 1984. Colony assays of hematopoietic progenitor cells and correlations to clinical situations. Crit. Rev. Oncol. Hematol. 1:227-257.
36. Jang, J. S., Y. Y. Choi, W. K. Lee, J. E. Choi, S. I. Cha, Y. J. Kim, C. H. Kim, S. Kam, T. H. Jung, and J. Y. Park. 2008. Telomere length and the risk of lung cancer. Cancer Sci. 99:1385-1389.
37. Kuriyama, K., M. Tomonaga, T. Matsuo, I. Ginnai, and M. Ichimaru. 1986. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micromegakaryocytes in myelodysplastic syndrome. Br. J. Haematol. 63:665-669.
38. Méndez-Ferrer, S., T. V. Michurina, F. Ferraro, A. R. Mazloom, B. D. Macarthur, S. A. Lira, D. T. Scadden, A. Ma'ayan, G. N. Enikolopov, and P. S. Frenette. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834.
39. Cipolleschi, M. G., P. Dello Sbarba, and M. Olivotto. 1993. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82:2031-2037.
40. Lee, C. H., B. Shah, E. K. Moioli, and J. J. Mao. 2010. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J. Clin. Invest. 120:3340-3349.
41. Leitinger, B. 2011. Transmembrane collagen receptors. Annu. Rev. Cell Dev. Biol. 27:265-290.
42. Tsutsumi, S., A. Shimazu, K. Miyazaki, H. Pan, C. Koike, E. Yoshida, K. Takagishi, and Y. Kato. 2001. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 288:413-419.
43. Zaragosi, L. E., G. Ailhaud, and C. Dani. 2006. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adiposederived stem cells. Stem Cells 24:2412-2419.
44. Monteiro, J. P., A. Benjamin, E. S. Costa, M. A. Barcinski, and A. Bonomo. 2005. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood 105:1484-1491.
45. Pereira, R. M., E. R. Velloso, Y. Menezes, S. Gualandro, J. Vassalo, and N. H. Yoshinari. 1998. Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin. Rheumatol. 17:219-222.
46. Pullarkat, V., R. D. Bass, J. Z. Gong, D. I. Feinstein, and R. K. Brynes. 2003. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am. J. Hematol. 72:8-12.
47. Gabele, E., D. A. Brenner, and R. A. Rippe. 2003. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front. Biosci. 8:d69-d77.
48. Puche, J. E., Y. A. Lee, J. Jiao, C. Aloman, M. I. Fiel, U. Muñoz, T. Kraus, T. Lee, H. F. Yee, Jr., and S. L. Friedman. 2013. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology 57:339-350.
49. Noble, P. W., C. E. Barkauskas, and D. Jiang. 2012. Pulmonary fibrosis: patterns and perpetrators. J. Clin. Invest. 122:2756-2762.
50. Ito, T., R. Sawada, Y. Fujiwara, and T. Tsuchiya. 2008. FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology 56:1-7.
51. Ko, E., K. Y. Lee, and D. S. Hwang. 2012. Human umbilical cord blood-derived mesenchymal stem cells undergo cellular senescence in response to oxidative stress. Stem Cells Dev. 21:1877-1886.
52. Ito, T., R. Sawada, Y. Fujiwara, Y. Seyama, and T. Tsuchiya. 2007. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by downregulation of TGF-beta2. Biochem. Biophys. Res. Commun. 359:108-114.
53. Deshpande, P., M. M. Cavanagh, S. Le Saux, K. Singh, C. M. Weyand, and J. J. Goronzy. 2013. IL-7-and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J. Immunol. 190:1416-1423.
54. Di Rosa, F., and R. Pabst. 2005. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26:360-366.
55. Di Rosa, F., and A. Santoni. 2003. Memory T-cell competition for bone marrow seeding. Immunology 108:296-304.
56. Loughran, T. P., Jr. 1993. Clonal diseases of large granular lymphocytes. Blood 82:1-14.
57. Epling-Burnette, P. K., J. H. Liu, R. Catlett-Falcone, J. Turkson, M. Oshiro, R. Kothapalli, Y. Li, J. M. Wang, H. F. Yang-Yen, J. Karras, et al. 2001. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107:351-362.
58. Epling-Burnette, P. K., F. Bai, S. Wei, P. Chaurasia, J. S. Painter, N. Olashaw, A. Hamilton, S. Sebti, J. Y. Djeu, and T. P. Loughran. 2004. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 23:9220-9229.
59. Schade, A. E., J. J. Powers, M. W. Wlodarski, and J. P. Maciejewski. 2006. Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 107:4834-4840.
60. Takizawa, H., S. Boettcher, and M. G. Manz. 2012. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119:2991-3002.
61. James, S. P., and E. A. Jones. 1985. Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells. Gastroenterology 89:165-171.
62. Katz, S. C., K. Ryan, N. Ahmed, G. Plitas, U. I. Chaudhry, T. P. Kingham, S. Naheed, C. Nguyen, P. Somasundar, N. J. Espat, et al. 2011. Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J. Immunol. 187:1150-1156.
63. Koskela, H. L., S. Eldfors, P. Ellonen, A. J. van Adrichem, H. Kuusanmäki, E. I. Andersson, S. Lagström, M. J. Clemente, T. Olson, S. E. Jalkanen, et al. 2012. Somatic STAT3 mutations in large granular lymphocytic leukemia. N. Engl. J. Med. 366:1905-1913.
64. Jerez, A., M. J. Clemente, H. Makishima, H. Koskela, F. Leblanc, K. Peng Ng, T. Olson, B. Przychodzen, M. Afable, I. Gomez-Segui, et al. 2012. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120:3048-3057.
65. Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig, B. J. Huntly, T. J. Boggon, I. Wlodarska, J. J. Clark, S. Moore, et al. 2005. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387-397.
66. Levine, R. L., and D. G. Gilliland. 2008. Myeloproliferative disorders. Blood 112:2190-2198.
67. Young, N. S., A. Bacigalupo, and J. C. Marsh. 2010. Aplastic anemia: pathophysiology and treatment. Biol. Blood Marrow Transplant. 16:S119-S125.
68. Saunthararajah, Y., R. Nakamura, R. Wesley, Q. J. Wang, and A. J. Barrett. 2003. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome. Blood 102:3025-3027.